European Commission approves listing of Sanofi/Lexicon's Zynquista
-
Last Update: 2020-06-10
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
recently, the European Commission approved the launch of Sanofi/Lexicon
(http://, with 200 mg per day and 400 mg as an insulin-assisted therapy for patients with type 1 diabetes (BMI 27) that controls poor blood sugar with the optimal dose of insulin aloneEU approval of sotagliflozin is based primarily on evidence from the inTandem clinical projectThe inTandem program consists of three Phase III clinicaltrial strial(http://, involving approximately 3,000 patients with type 1 diabetes with poor blood sugar level controlresults showed that 200mg, 400mg as an oral complementary therapy for insulin, after 24 weeks of treatment, improved the patient's HbA1c level, weight, systolic pressure and baseline level systolic and the single insulin therapy significantly, and no significant increase in severe hypoglycemia eventsSanofi partnered with Lexicon in 2015 to acquire development and commercial interests in sotagliflozin for a $300 million down payment and $1.4 billion in research and development, registration, and sales of mileagesotagliflozin is also conducting clinical studies in patients with type 2 diabetes, and 11 clinical studies are currently under way, including two studies on people with type 2 diabetes with combined kidney damage and two large cardiovascular outcomestudies
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
